LHX3 is an early stage and radiosensitivity prognostic biomarker in lung adenocarcinoma

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. We previously identified LHX3 as a new preferentially expressed gene in NSCLC. In the present study, we sought to determine its expression, the clinical relevance and the functional roles in NSCLC. LHX3 expression is sharply...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Xin, Li, Yan, Wang, Jin, Han, Fei, Lu, Shuang, Wang, Yu, Luo, Wenjian, Zhang, Mingqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549242/
https://www.ncbi.nlm.nih.gov/pubmed/28731174
http://dx.doi.org/10.3892/or.2017.5833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549242/
https://www.ncbi.nlm.nih.gov/pubmed/28731174
http://dx.doi.org/10.3892/or.2017.5833

Ejemplares similares